Skip to main content
. 2017 Apr 26;16(1):12–18. doi: 10.5114/pm.2017.66178

Fig. 3.

Fig. 3

Erα-immunoreactivity in the vaginal epithelium, before and after three months of therapy: A, B – oral, C, D – transdermal and E, F – topical. Original magnification 200×